Researcher
Paul Cos
- Research Expertise:In vitro and in vivo biofilm assays, Integrated antimicrobial (bacteria, fungi, yeasts and parasites) screening and profiling of pure compounds and extracts, targeting redox homeostasis in mycobacteria
- Keywords:MICROBIOLOGY, BACTERIOLOGY, BIOFILMS, INFLAMMATION, Pharmacy and pharmacology
- Disciplines:Microbiology, Systems biology, Laboratory medicine
- Research techniques:In vitro and in vivo (pre-clinical) models of infectious diseases (bacteria and fungi), evaluation of drugs
- Users of research expertise:Pharmaceutical companies (big pharma, SME, spin-off), news agencies, journalists, government agencies, regulatory (EU) agencies, non-governmental organisations in the field of infectious diseases
Affiliations
- Laboratory for Microbiology, Parasitology and Hygiene (LMPH) (Research group)
Responsible
From1 Oct 2020 → Today - Laboratory for Microbiology, Parasitology and Hygiene (LMPH) (Research group)
Member
From1 Oct 2006 → 30 Sep 2020
Projects
1 - 10 of 56
- SEP BOF 2022 - DelNAM PlusFrom1 Dec 2022 → TodayFunding: BOF - projects
- Prevention of ventilator-associated pneumonia: analysis of the in vitro and in vivo anti-biofilm capacity of cecropin-based coatings on endotracheal tubes.From1 Nov 2022 → TodayFunding: FWO fellowships
- Infrastructure for Diverse Applications of Single Cell Sorting and Dispensing using Microfluidics.From1 Jun 2022 → TodayFunding: BOF - scientific equipment program
- Implementation of in vivo models to identify potential candidates for treatment of Dry Eye DiseaseFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - projects
- Persistence in Streptococcus pneumoniae infections: elucidation of the importance of persister cells in chronic and recurrent infectionsFrom1 Nov 2020 → TodayFunding: FWO fellowships
- In vivo evaluation of biofilm-related pneumonia.From1 Oct 2020 → 30 Sep 2021Funding: BOF - projects
- Springboard for excellence in advanced development of antibacterials (SPRINGBOARD).From1 Sep 2020 → TodayFunding: H2020 - Spreading excellence and widening participation
- 3D printing of drug loaded medical devices for personalized medicine.From1 May 2020 → 30 Apr 2022Funding: IOF - technology concept exploration
- The exploration of novel rapid technologies and alternatives to conventional microbiological test approaches (μRATE).From1 Apr 2020 → TodayFunding: VLAIO - research project companies
- A platform to functionally assess clinically relevant respiratory parameters in small animal models for infectious and non-infectious pulmonary research.From1 Jan 2020 → 31 Dec 2021Funding: BOF - scientific equipment program
Publications
1 - 10 of 254
- Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease(2022)
Authors: Charlotte Rigauts, Juliana Aizawa Porto de Abreu, Steven L. Taylor, Geraint B. Rogers, Matthias Govaerts, Paul F R C M Cos, Lisa Ostyn, Sarah Sims, Eva Vandeplassche, Mozes Sze, et al.
Pages: 1 - 16 - 3D-printed gentamicin-releasing poly-ε-caprolactone composite prevents fracture-related Staphylococcus aureus infection in mice(2022)
Authors: Clara Guarch-Pérez, Bahaa Shaqour, Martijn Riool, Bart Verleije, Koen Beyers, Chris Vervaet, Paul F R C M Cos, Sebastian A.J. Zaat
Pages: 1 - 17 - LC-MS characterization and biological activities of Cuban cultivars of Plectranthus neochilus Schltr(2022)
Authors: Annarli O. Rodríguez-Ferreiro, Ania Ochoa-Pacheco, Daniel Méndez-Rodriguez, Emilia Ortiz-Beatón, Oneida Font-Salmo, Frenkel Guisado-Bourzac, Silvia Molina-Bertrán, Lianet Monzote, Paul F R C M Cos, Kenn Foubert, et al.
- Design, synthesis and biological evaluation of benzo-[d]-imidazo-[2,1-b]-thiazole and imidazo-[2,1-b]-thiazole carboxamide triazole derivatives as antimycobacterial agents(2022)
Authors: Surendar Chitti, Kevin Van Calster, Davie Cappoen, Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Paul F R C M Cos, Banoth Karan Kumar, Sankaranarayanan Murugesan, Kondapalli Venkata Gowri Chandra Sekhar
Pages: 22385 - 22401 - A niclosamide-releasing hot-melt extruded catheter prevents **Staphylococcus aureus** experimental biomaterial-associated infection(2022)
Authors: Jesus Augusto Vazquez-Rodriguez, Bahaa Shaqour, Clara Guarch-Pérez, Emilia Choińska, Martijn Riool, Bart Verleije, Koen Beyers, Vivian J.A. Costantini, Wojciech Święszkowski, Sebastian A.J. Zaat, et al.
Pages: 1 - 15 - Inhibition of bacterial adhesion and biofilm formation by seed-derived ethanol extracts from **Persea americana** Mill(2022)
Authors: Silvia del Carmen Molina Bertrán, Lianet Monzote, Davie Cappoen, Julio Cesar Escalona Arranz, Mario Juan Gordillo Pérez, Annarli O. Rodríguez-Ferreiro, Idelsy Chill Nuñez, Claudina Perez Novo, Daniel Méndez, Paul F R C M Cos, et al.
Pages: 1 - 13 - Technological, biochemical and microbiological evaluation of dehydrated Pleurotus ostreatus powder for nutraceutical applications(2022)
Authors: Daily Arias-Ramos, Idelsy Chil-Nunez, Humberto J. Morris, Miladis Camacho-Pozo, Yamila Lebeque-Perez, Gabriel Llaurado-Maury, Paul F R C M Cos, Chris Vervaet
Pages: 507 - 514 - In vitro evaluation of antimicrobial peptides from the black soldier fly (**Hermetia illucens**) against a selection of human pathogens(2022)
Authors: Laurence Van Moll, Jeroen De Smet, Anne Paas, Dorothee Tegtmeier, Andreas Vilcinskas, Paul F R C M Cos, Leen Van Campenhout
Pages: 1 - 17 - In vitro pharmacological screening of essential oils from Baccharis parvidentata and Lippia origanoides growing in Brazil(2022)
Authors: Wilmer H. Perera, Alexander M. Scherbakov, Galina, I. Buravchenko, Ekaterina, I. Mikhaevich, Suzana Guimaraes Leitao, Paul F R C M Cos, Andrey E. Shchekotikhin, Lianet Monzote, William N. Setzer
Pages: 1 - 11 - Phenols from Origanum dictamnus L. and Thymus vulgaris L. and their activity against Malassezia globosa carbonic anhydrase(2022)
Authors: Charikleia Paloukopoulou, Sofia Govari, Athina Soulioti, Ilias Stefanis, Andrea Angeli, An Matheeussen, Clemente Capasso, Paul F R C M Cos, Claudiu T. Supuran, Anastasia Karioti
Pages: 1558 - 1564
Patents
1 - 5 of 5
- Compositions against candida infections (Inventor)
- Bis(acetamidophenyl) guanidinophenyethylphosphonates for use in the prevention and/or treatment of PAR-related diseases (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
- Compositions against candida infections (Inventor)
- Bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of par-related diseases (Inventor)
Linked dataset
1 - 1 of 1